Form 4: Quest Diagnostics Director Lassiter Wright III Reports Stock Award and Disposal

Director Lassiter Wright III reports acquisition of 1,203 shares of Quest Diagnostics common stock through a restricted stock unit award and disposal of 9,037 shares on May 15, 2025.

Summary

• On May 15, 2025, Wright L. Lassiter III, a director of Quest Diagnostics Inc., reported a transaction involving the company's common stock.
• Lassiter acquired 1,203 shares through an award of restricted stock units.
• Simultaneously, Lassiter disposed of 9,037 shares of common stock.
• Following these transactions, Lassiter directly owns 9,037 shares of Quest Diagnostics Inc.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, reflecting routine stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The transactions may be of interest to shareholders as they provide insight into the actions of a company director.

Key Dates

Keywords

Form 4, Quest Diagnostics, Director, Stock Transaction, Beneficial Ownership, Lassiter Wright III, DGX, Restricted Stock Units